Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Relapse in Schizophrenia-Reply

Relapse in Schizophrenia-Reply Abstract We thank Dr Goldhamer for making explicit yet another probable factor related to relapse among schizophrenic patients. His insights regarding the Kafka-like consequences of depot preparations are most relevant as the number of longacting neuroleptics multiply internationally and their application encompasses increasingly large populations of schizophrenic patients. The thrust of Dr Goldhamer's argument is that depot preparations would significantly lower relapse in the first year after discharge relative to oral medications if the psychological devastation and social consequences secondary to forced compliance were to be negotiated psychotherapeutically. We, too, believe that the dysphoria that might follow on forced compliance is likely to be at least an intervening variable that contributes to the relapse of some patients, although empirical evidence for this conclusion regarding schizophrenic patients generally is indirect. Dr Goldhamer, however, draws attention to the important interface between pharmacological and psychotherapeutic strategies in the treatment of schizophrenia, an area frequently References 1. Ostow M: The contribution of drug therapy to psychoanalysis and psychotherapy. Read before the Einstein College of Medicine symposium, The Interrelationship of Psychotherapy and Psychopharmacology, New York, April 12, 1980. 2. Sarwer-Foner G: Combined psychopharmacology and psychotherapy. Read before the Einstein College of Medicine Symposium, The Interrelationship of Psychotherapy and Psychopharmacology, New York, April 12, 1980. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Archives of General Psychiatry American Medical Association

Relapse in Schizophrenia-Reply

Abstract

Abstract We thank Dr Goldhamer for making explicit yet another probable factor related to relapse among schizophrenic patients. His insights regarding the Kafka-like consequences of depot preparations are most relevant as the number of longacting neuroleptics multiply internationally and their application encompasses increasingly large populations of schizophrenic patients. The thrust of Dr Goldhamer's argument is that depot preparations would significantly lower relapse in the first...
Loading next page...
 
/lp/american-medical-association/relapse-in-schizophrenia-reply-mRF9B0Ok9K
Publisher
American Medical Association
Copyright
Copyright © 1981 American Medical Association. All Rights Reserved.
ISSN
0003-990X
eISSN
1598-3636
DOI
10.1001/archpsyc.1981.01780320123017
Publisher site
See Article on Publisher Site

Abstract

Abstract We thank Dr Goldhamer for making explicit yet another probable factor related to relapse among schizophrenic patients. His insights regarding the Kafka-like consequences of depot preparations are most relevant as the number of longacting neuroleptics multiply internationally and their application encompasses increasingly large populations of schizophrenic patients. The thrust of Dr Goldhamer's argument is that depot preparations would significantly lower relapse in the first year after discharge relative to oral medications if the psychological devastation and social consequences secondary to forced compliance were to be negotiated psychotherapeutically. We, too, believe that the dysphoria that might follow on forced compliance is likely to be at least an intervening variable that contributes to the relapse of some patients, although empirical evidence for this conclusion regarding schizophrenic patients generally is indirect. Dr Goldhamer, however, draws attention to the important interface between pharmacological and psychotherapeutic strategies in the treatment of schizophrenia, an area frequently References 1. Ostow M: The contribution of drug therapy to psychoanalysis and psychotherapy. Read before the Einstein College of Medicine symposium, The Interrelationship of Psychotherapy and Psychopharmacology, New York, April 12, 1980. 2. Sarwer-Foner G: Combined psychopharmacology and psychotherapy. Read before the Einstein College of Medicine Symposium, The Interrelationship of Psychotherapy and Psychopharmacology, New York, April 12, 1980.

Journal

Archives of General PsychiatryAmerican Medical Association

Published: Jul 1, 1981

There are no references for this article.